Press releases, events and news from Complix

You can meet us at numerous conferences and events, but we also like to keep you up to date through our website. Stay informed about Complix, and discover valuable information about our research and technology

28 Jul Complix Signs Global Drug Discovery and Development Agreement with Jiangsu Nhwa Pharmaceutical Co. to Develop Novel Alphabody Therapeutics for Treatment of CNS Diseases

Posted at 10:00h in News

Read More

31 Mar Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies in Science Advances

Posted at 08:00h in News

Read More

10 Mar Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets

Posted at 15:00h in News

Read More

07 Oct Complix receives €1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody™ therapeutics

Posted at 07:00h in News

Read More

08 May Complix to Present Progress on its Pipeline of Cell Penetrating Alphabodies at BioEquity Europe 2019

Posted at 08:00h in Events

Read More

12 Nov Complix to Present its Cell Penetrating Alphabodies Acting on Important Intracellular Targets at PEGS Europe 2018

Posted at 08:00h in Events

Read More

19 Sep A new technology for targeting proteins inside cells

Posted at 08:00h in News

Read More

09 May Complix to Present Progress on its Pipeline of Cell Penetrating Alphabodies Acting on Intracellular Cancer Targets at BioEquity Europe 2018

Posted at 08:00h in Events

Read More

14 Dec Complix receives €0.5 million grant to further develop its pipeline of proprietary Cell Penetrating Alphabodies™ against intracellular cancer targets

Posted at 09:00h in News

Read More

31 Oct Complix to Present its Cell Penetrating Alphabody™ Platform Acting on Important Intracellular Targets at PEGS Europe 2017

Posted at 09:00h in Events

Read More

1
2